Guobang Pharma Ltd.SSE: 605507

Report for Q1 2025

Apr 16, 2025 · Issued by Guobang Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 16, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-442

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Guobang Pharma Ltd. on 6ix

Earlier from Guobang Pharma

Announcement on Resolution of the 12th Meeting of the 2nd Board of DirectorsMar 28, 2025
Announcement on Receiving the Letter of Commitment for Buyback LoanMar 21, 2025
Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Restrictions Concerning RepurchaseMar 15, 2025
Announcement on Repurchasing Shares through Call AuctionMar 11, 2025
Announcement on Wholly-owned Subsidiary Receiving Notice of Approval for Marketing Application of Chemical APIsFeb 28, 2025

Later from Guobang Pharma

All Guobang Pharma news releases

Follow Guobang Pharma into a list and get an email when it puts out news.

Follow Guobang Pharma